Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients - Journal of Human Hypertension
- ️Preti, P
- ️Thu Nov 24 2005
Skoog I, Lernfeldt B, Landahl S, Palmertz B, Andersson LA, Nilsson L et al. Fifteen-year longitudinal study of blood pressure and dementia. Lancet 1996; 34: 1141–1145.
Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR et al. Midlife blood pressure and dementia: the Honolulu-Asia aging Study. Neurobiol Aging 2000; 21: 49–55.
Alves de Moraes S, Szklo M, Knopman D, Sato R . The relationship between temporal changes in blood pressure and changes in cognitive function. Atherosclerosis Risk in Communities (ARIC) Study. Prev Med 2002; 35: 258–263.
Farmer ME, Kittner SJ, Abbott RD, Wolz NM, White LR . Blood pressure and cognitive performance: the Framingham Study. Am J Epidemiol 1987; 126: 1103–1114.
Starr JM, Whalley LJH, Deary IJ . The effects of antihypertensive treatment on cognitive function: results from the HOPE Study. J Am Geriatr Soc 1996; 44: 411–415.
Prince MJ, Bird AS, Blizard RA, Mann AH . Is cognitive function of older patients affected by antihypertensive treatment? Results from the Medical Research Council's trial of hypertension in older adults. BMJ 1996; 312: 801–805.
Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager W . Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347–1351.
Guo Z, Fratiglioni L, Zhu L, Fastbom J, Winblad B, Viitanen M . Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol 1999; 56: 991–996.
Gaard PR . The role of angiotensin II in cognition and behaviour. Eur J Pharmacol 2002; 438: 1–14.
Culman J, Blume A, Gohlke P, Unger T . The renin–angiotensin system in the brain: possible therapeutic implications for AT1-receptor blockers. J Hum Hypertens 2002; 16: S64–S70.
Baranowska D, Braszko JJ, Wisniewski K . Effect of angiotensin II on acquisition and extinction of conditioned avoidance in rats. Psychopharmacology 1983; 81: 247–251.
Braszko JJ, Wisniewski K, Kupryszewski G, Witczuk B . Psychotropic effects of angiotensin II and angiotensin III in rat: locomotor and exploratory vs cognitive behaviour. Behav Brain Res 1987; 25: 195–203.
Barnes JM, Barnes NM, Costall B, Horovitz ZP, Naylor RJ . Angiotensin II inhibits the release of (3H) acetylcholine from the rat entorhinal cortex in vitro. Brain Res 1989; 492: 136–143.
Vanhoutte PM . How to assess endothelial function in human blood vessels. J Hypertens 1999; 17: 1047–1058.
Barnes JM, Barnes NM, Costall B . Ace-inhibition and cognition. In Mc Gregor GA, Sever PS (eds). Current Advances in ACE-inhibition. Churchill-Livingstone: London, 1989, pp 159–171.
Mondadori C, Etienne P . Nootropic effects of ACE inhibitors in mice. Psychopharmacol 1990; 100: 301–307.
Starr JM, Whalley LJ . ACE-inhibitors: Central Actions. Raven Press: New York, 1994.
Raghavendra V, Chopra K, Kulkarni SK . Comparative studies on the memory enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Neuropeptides 2001; 35: 65–69.
Tedesco MA, Ratti G, Mennella S, Manzo G, Grieco M, Rainone AC et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am J Hypertens 1999; 12: 1130–1134.
Ebert U, Kirch W . Effects of captopril and enalapril on electroencephalogram and cognitive performance in healthy volunteers. Eur J Clin Pharmacol 1999; 55: 255–257.
Fogari R, Mugellini A, Zoppi A, Derosa G, Pasotti C, Fogari E et al. Influence of losartan and atenolol on cognitive function in very elderly hypertensive patients. J Hum Hypertens 2003; 17: 781–785.
Fogari R, Mugellini A, Zoppi A, Derosa G, Pasotti C, Fogari E et al. Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. Eur J Clin Pharmacol 2004; 59: 863–868.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 2003; 289: 2534–2573.
2003 European Society of Hypertension-European Society of Cardiology Guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.
Puschett JB . Diuretics. In: Oparil S, Weber MA (eds). Hypertension: A Companion to Brenner and Rector's The Kidney. W.B. Saunders Company: Philadelphia, 2000, pp 584–590.
Weber MA . Rationalizing the treatment of hypertension. Am J Hypertens 2001; 14: 3S–7S.
McClellan KJ, Markham A . Telmisartan. Drugs 1998; 56: 1039–1044.
Lancaster SG, Todd PA . Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure. Drugs 1988; 35: 646–669.
Starr JM, Whalley LJ . Senile hypertension and cognitive impairment. An overview. J Hypertens 1992; 10(Suppl): S31–S42.
Hansson L, Hedner T, Dahlof B . Prospective, randomized, open label, blinded-end point (PROBE) study: a novel design for intervention trials. Blood Press 1992; 1: 113–114.
Groppelli A, Omboni S, Ravogli A, Villani A, Parati G, Mancia G . Validation of the Spacelabs 90202 and 90297 devices for ambulatory blood pressure monitoring by comparison with intra-arterial resting and ambulatory measurements. J Hypertens 1991; 9(Suppl 3): S334–S335.
US Food and Drugs Administration. Proposed guidelines for the Clinical Evaluation of Antihypertensive Drugs. US Department of Health and Human Services, Division od Cardio-Renal Drug Products: Rockville, MD, 1988.
Omboni S, Parati G, Zanchetti A, Mancia G . Calculation of trough: peak ratio of antihypertensive treatment from ambulatory blood pressure. Methodological aspects. J Hypertens 1995; 13: 1105–1112.
Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G . The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998; 16: 1685–1691.
Isaacs B, Kennie AT . The SET test as an aid to the detection of dementia in old people. Br J psychiatr 1973; 123: 467–470.
Tranel D . Neuropsychological assessment. Psychiatr Clin North Am 1992; 15: 283–299.
Kaplan EF, Goodglass H, Weinstraub S . The Boston naming test. Veterans Administration Medical Center: Boston, 1978.
Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A . Consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39: 1159–1165.
Mohs RC, Kim Y, Johus CA . Assessing change in Alzheimer's disease: memory and language tests. In: Poon LW (ed). Handbook for Clinical Memory Assessment of Older Adults. American Psychological Association: Washington, 1986, pp 149–155.
Reitan R . validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271–276.
White WB . Blood pressure load and target organ effects in patients with essential hypertension. J Hypertens 1991; 9(Suppl 8): S39–S41.
Squire LR . Memory and Brain. Oxford University Press: Oxford, 1987.
Cabeza R, Nyberg L . Imaging cognition: an empirical review of PET studies with normal subjects. J Cogn Neurosci 1997; 9: 1–26.
Fahlander K, Wahlin A, Fastbom J, Grut M, Forsell Y, Hill R et al. The relationship between signs of cardiovascular deficiency and cognitive performance in old age: a population based study. J Gerontol B Psychol Sci Soc Sci 200; 55: P259–P265.
Backman L, Small B, Wahlin A, Larsson M . Cognitive functioning in very old age. In: Cruik FIM, Salthouse TA (eds). The Handbook of Aging and Cognition, 2nd edn. Erlbaum: Muhwah, NJ, pp 499–558.
Raghawendra V, Chopra K, Kulkarni SK . Comparative studies of the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance in mice using inhibitory shock avoidance paradigm. Neuropeptides 2001; 35: 65–69.
Barnes NM, Champaneria S, Costall B, Kelly ME, Murphy DA . Cognitive enhancing actions of DuP 753 detected in a mouse habituation paradigm. Neuroreport 1990; 1: 239–242.
Okuyama S, Sakagawa T, Inagami T . Role of the ang II type 2 receptors in the mouse central nervous system. Jpn J Pharmacol 1999; 81: 259–263.
Wright JW, Stubley LA, Pederson ES, Kramar EA, Hanesworth J, Harding JW . Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. J Neurosci 1999; 19: 3952–3961.
Pederson ES, Krishnan R, Harding JW, Wright JW . A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits. Regul Pept 2001; 102: 147–156.
Goldstein G, Materson BJ, Cushman WC, Reda DJ, Freis ED, Ramirez EA et al. Treatment of hypertension in the elderly(II): cognitive and behavioural function. Hypertension 1990; 15: 361–369.
Vanmolkot FHM, DeHoon JNJN, Van de Ven LLM, Van Bortel LMAB . Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide. J Hum Hypertens 1999; 13: 559–563.